Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Centenary Institute heart research features in the Sydney Morning Herald

Centenary Institute heart research features in the Sydney Morning Herald

Date time 28 November, 2022
News Type News type Media coverage
Dr Julia Isbister
The Sydney Morning Herald has reported study findings from the Centenary Institute that found that concealed cardiomyopathy – heart muscle disease that can cause fatal heart rhythms – is an important cause of sudden cardiac death where no cause is found from autopsy.

The article, written by journalist Kate Aubusson, detailed that genetic testing can now help identify cases of concealed cardiomyopathy, which provides two key benefits – a cause of death and closure for families, and knowledge that can help guide care of surviving relatives.

Lead study author Dr Julia Isbister, a PhD student at the Centenary Institute’s Agnes Ginges Centre for Molecular Cardiology and University of Sydney – and senior study author, Professor Christopher Semsarian AM, Head of the Agnes Ginges Centre for Molecular Cardiology and  cardiologist at Royal Prince Alfred Hospital – say that genetic testing of sudden cardiac death cases which are unexplained after autopsy should be broader so that concealed cardiomyopathy can be better identified.

The full Sydney Morning Herald article can be accessed online.

Further information on the Agnes Ginges Centre for Molecular Cardiology can be found on the Centenary Institute website here.

Themes

  • Cardiovascular Research

    Cardiovascular Research

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • Centenary exhibition brings medical research to life in hospital spaces

    The Centenary Institute’s 'When Art Meets Science' exhibition took centre stage at the recent launch of the annual Sydney Local Health District (SLHD) March Arts program.
    News Type: Community
    Date 04 Mar 2026
  • ‘Mini hearts’ show COVID-19 virus directly infects heart tissue

    Researchers from the Centenary Institute and the University of Technology Sydney (UTS) have developed a human heart cell model demonstrating that the virus that causes COVID‑19 (SARS-CoV-2) can directly infect heart tissue, providing new insight into why some people experience serious heart complications during and after infection.
    News Type: Media release
    Date 03 Mar 2026
  • Emerging class of antibiotics to tackle global tuberculosis crisis

    Researchers from the University of Sydney and the Centenary Institute have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes tuberculosis (TB), paving the way for urgently needed new treatments.
    News Type: Media release
    Date 27 Feb 2026
  • Blood test discovery could help identify head and neck cancer patients at higher risk of relapse

    Researchers at the Centenary Institute, Chris O’Brien Lifehouse, NSW Health Pathology and Royal Prince Alfred Hospital have found a potential new way to help doctors identify which head and neck cancer patients may be at higher risk of their cancer returning, using a simple blood test.
    News Type: Media release
    Date 25 Feb 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram